share_log
Breakings ·  Jun 20 20:10
Esperion Therapeutics Inc : BofA Global Research Cuts Price Objective to $2.5 From $2.9
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment